Eversept Partners as of Sept. 30, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 61 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 11.5 | $26M | 90k | 290.72 | |
| Zogenix Com New | 9.1 | $21M | 419k | 49.60 | |
| R1 Rcm | 7.5 | $17M | 1.7M | 10.16 | |
| Amarin Corp Spons Adr New | 7.1 | $16M | 996k | 16.27 | |
| Sanofi Sponsored Adr (SNY) | 5.5 | $13M | 281k | 44.67 | |
| Glaxosmithkline Sponsored Adr | 5.2 | $12M | 289k | 40.60 | |
| Merck & Co (MRK) | 4.6 | $11M | 148k | 71.42 | |
| Radius Health Com New | 4.1 | $9.4M | 529k | 17.80 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.1 | $9.3M | 48k | 192.74 | |
| Teligent | 3.7 | $8.3M | 2.1M | 3.95 | |
| Aerie Pharmaceuticals | 3.3 | $7.4M | 121k | 61.55 | |
| Sarepta Therapeutics (SRPT) | 3.0 | $6.8M | 42k | 161.51 | |
| Sage Therapeutics (SAGE) | 2.7 | $6.2M | 44k | 141.25 | |
| Abbott Laboratories (ABT) | 2.4 | $5.5M | 75k | 73.36 | |
| Arena Pharmaceuticals Com New | 2.4 | $5.5M | 119k | 46.02 | |
| Ensign (ENSG) | 2.2 | $5.1M | 135k | 37.97 | |
| Danaher Corporation (DHR) | 1.7 | $3.9M | 36k | 108.82 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $2.8M | 210k | 13.20 | |
| Medtronic SHS (MDT) | 1.2 | $2.6M | 27k | 98.87 | |
| Anaptysbio Inc Common (ANAB) | 1.0 | $2.2M | 23k | 99.77 | |
| Madrigal Pharmaceuticals (MDGL) | 0.9 | $2.0M | 9.4k | 214.13 | |
| Wright Med Group N V Ord Shs 0.03 Par | 0.8 | $1.9M | 67k | 29.02 | |
| Affimed Therapeutics B V | 0.8 | $1.9M | 433k | 4.35 | |
| Argenx Se Sponsored Adr (ARGX) | 0.8 | $1.8M | 24k | 75.84 | |
| Apellis Pharmaceuticals (APLS) | 0.8 | $1.8M | 100k | 17.78 | |
| Foamix Pharmaceuticals SHS | 0.8 | $1.7M | 299k | 5.73 | |
| Spectrum Pharmaceuticals Put Option | 0.7 | $1.7M | 100k | 16.80 | |
| ArQule | 0.7 | $1.6M | 290k | 5.66 | |
| Invacare Corporation | 0.7 | $1.6M | 109k | 14.55 | |
| Abiomed | 0.7 | $1.5M | 3.4k | 449.75 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.6 | $1.4M | 19k | 70.86 | |
| BioSpecifics Technologies | 0.6 | $1.3M | 22k | 58.49 | |
| Model N (MODN) | 0.5 | $1.1M | 72k | 15.85 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $1.1M | 149k | 7.63 | |
| Puma Biotechnology (PBYI) | 0.4 | $994k | 22k | 45.85 | |
| Amicus Therapeutics (FOLD) | 0.4 | $964k | 80k | 12.09 | |
| Insulet Corporation (PODD) | 0.4 | $929k | 8.8k | 105.95 | |
| Caretrust Reit (CTRE) | 0.4 | $918k | 51k | 17.91 | |
| Array BioPharma | 0.4 | $918k | 60k | 15.20 | |
| Cymabay Therapeutics | 0.4 | $799k | 72k | 11.08 | |
| Dicerna Pharmaceuticals | 0.3 | $779k | 51k | 15.26 | |
| Tricida | 0.3 | $737k | 24k | 30.55 | |
| Orthopediatrics Corp. (KIDS) | 0.3 | $718k | 20k | 36.64 | |
| Sangamo Biosciences Call Option (SGMO) | 0.3 | $678k | 40k | 16.95 | |
| Dentsply Sirona (XRAY) | 0.3 | $631k | 17k | 37.83 | |
| Anthem (ELV) | 0.3 | $630k | 2.3k | 274.05 | |
| Centene Corporation (CNC) | 0.3 | $623k | 4.3k | 144.78 | |
| Albireo Pharma | 0.3 | $594k | 18k | 32.96 | |
| Epizyme | 0.2 | $503k | 47k | 10.60 | |
| Medicines Company | 0.2 | $500k | 17k | 29.91 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $497k | 44k | 11.25 | |
| Seaspine Holdings | 0.2 | $481k | 31k | 15.56 | |
| Dermira | 0.2 | $436k | 40k | 10.90 | |
| Viking Therapeutics (VKTX) | 0.2 | $436k | 25k | 17.42 | |
| Tg Therapeutics (TGTX) | 0.2 | $364k | 65k | 5.60 | |
| Ophthotech | 0.2 | $352k | 149k | 2.36 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.1 | $335k | 27k | 12.40 | |
| Conformis | 0.1 | $135k | 127k | 1.06 | |
| Applied Genetic Technol Corp C | 0.0 | $106k | 15k | 7.30 | |
| Melinta Therapeutics | 0.0 | $105k | 27k | 3.95 | |
| Vital Therapies Put Option | 0.0 | $11k | 38k | 0.28 |
